AstraZeneca AB et al v. Apotex Inc. et al
| AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Nektar Therapeutics |
| Apotex Inc. and Apotex Corp. |
| 1:2018cv02010 |
| December 18, 2018 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 28, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Andrew M. Alul,Stephen R. Auten,Brian P. Murray,Richard T. Ruzich for Apotex Corp., Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Pro Hac Vice Attorney Sumeet P. Dang for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
Filing 14
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 3/1/2019, at 4:15 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/24/2019. (nms)
|
| Pro Hac Vice Attorney Aaron P. Maurer for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA(ddp) |
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang, filed by Nektar Therapeutics, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 1/24/2019. (nms)
|
| Filing 13 ANSWER to #8 Answer to Complaint, Counterclaim by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 1/24/2019 (nms). |
| Filing 11 DECLARATION of Mailing regarding service on Apotex Inc. made on December 19, 2018, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 1/4/2019 (nms). |
| Filing 10 SUMMONS Returned Executed by Nektar Therapeutics, AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Apotex Corp. served on 12/19/2018, answer due 1/9/2019. (Silver, Daniel) |
| Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Filing 8 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by Apotex Inc., Apotex Corp..(Dorsney, Kenneth) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Brian P. Murray, Andrew M. Alul and Richard T. Ruzich, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 1/2/2019. (nms)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Brian P. Murray, Andrew M. Alul and Richard T. Ruzich - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate PRIMECAP Management Company, Other Affiliate The Vanguard Group, Other Affiliate Fidelity Management and Research LLC for Nektar Therapeutics filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (lak) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 11/5/2018. Date of Expiration of Patent: 4/4/2032. Thirty Month Stay Deadline: 5/5/2021. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT - filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2528116.) - filed by AstraZeneca AB, Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lak) |
| Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 12/18/2018; Apotex Inc. on 12/18/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
